We were delighted to catch up with touchONCOLOGY editorial board member Professor Robin Foà (Sapienza University of Rome, Italy) to discuss his educational session at the 63rd ASH Annual Meeting & Exposition on measurable residual disease in the management of many haematological malignancies. (PART THREE)
Questions
1. What is the current role of measurable residual disease (MRD) in guiding decision making in clinical practice? 00:15-03:38
2. What are the barriers to more widespread implementation of MRD in clinical practice and how are these being overcome? 03:38-06:16
Speaker Disclosure: Robin Foà has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the 63rd ASH Annual Meeting & Exposition
